Publication | Closed Access

Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin

InflammationToll-like ReceptorsAnti-inflammatorySignal TransductionAutoimmune DiseaseMedicineInnate Immune SystemImmunologyChronic InflammationImmunopathologyPharmacologyCell Signaling